Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Ejhaem|December 5, 2022
Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemiaJae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, et al.
Bone Marrow Transplantation|February 28, 2019
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)Jae-Ho Yoon, Keon Hee Yoo, Ki Woong Sung, et al.
Hematology (Amsterdam, Netherlands)|March 4, 2024
Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabineMihee Kim, Seo-Yeon Ahn, TaeHyung Kim, et al.
Nature Communications|February 14, 2026
Blood-based epigenetic instability linked to human aging and diseaseSalman Basrai, Ido Nofech-Mozes, Rajesh Detroja, et al.
BMC Cancer|August 10, 2016
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimenSung-Hoon Jung, Min-Seok Cho, Hee Kyung Kim, et al.
Annals of Hematology|April 6, 2011
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulinsDeok-Hwan Yang, Mi-Hyun Kim, Youn-Kyung Lee, et al.
Cancers|June 13, 2025
Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell LymphomaGa-Young Song, Joo Heon Park, Sae-Ryung Kang, et al.
Cell Transplantation|July 21, 2022
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHDDong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, et al.
Annals of Hematology|March 19, 2010
Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cellsDeok-Hwan Yang, Mi-Hyun Kim, Cheol Yi Hong, et al.
Journal of Korean Medical Science|June 23, 2009
The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemiaSe Ryeon Lee, Deok Hwan Yang, Jae Sook Ahn, et al.
Pageof 16